SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from X4 Pharmaceuticals, Inc (XFOR) (CIK 0001501697) (XFOR) — Feb 12, 2019

X4 Pharmaceuticals, Inc (XFOR) (CIK 0001501697)
Date: Feb. 12, 2019 · CIK: 0001501697 · Accession: 0001193125-19-035896

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-229377

Date
February 12, 2019
Author
Michael P. Gray
Form
CORRESP
Company
X4 Pharmaceuticals, Inc (XFOR) (CIK 0001501697)

Letter

Arsanis, Inc.

950 Winter Street, Suite 4500

Waltham, MA 02451

February 12, 2019

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re: Arsanis, Inc.

Registration Statement on Form S-3

File No. 333-229377

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Arsanis, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-229377), as amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern time on February 14, 2019, or as soon thereafter as practicable.

[Remainder of Page Intentionally Left Blank]

Very truly yours,
ARSANIS, INC.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 Arsanis, Inc.

950 Winter Street, Suite 4500

 Waltham, MA 02451

February 12, 2019

 VIA EDGAR

Securities and Exchange Commission

 Division of Corporation
Finance

 100 F Street, N.E.

 Washington, D.C. 20549

Re:
 Arsanis, Inc.

 Registration Statement on Form S-3

 File No. 333-229377

 Request for Acceleration

Ladies and Gentlemen:

 Pursuant to Rule 461 promulgated under
the Securities Act of 1933, as amended, Arsanis, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-229377), as amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern time on February 14, 2019, or as soon thereafter as practicable.

[Remainder of Page Intentionally Left Blank]

Very truly yours,

ARSANIS, INC.

By:

/s/ Michael P. Gray

Name:

Michael P. Gray

Title:

 President and Chief Executive Officer,

 Chief
Financial Officer

 Signature Page to Acceleration Request